Reuters logo
3 个月前
BRIEF-Orexigen Therapeutics announces new drug submission for Contrave in Canada
2017年4月25日 / 早上6点31分 / 3 个月前

BRIEF-Orexigen Therapeutics announces new drug submission for Contrave in Canada

1 分钟阅读

April 25 (Reuters) - Orexigen Therapeutics Inc

* Orexigen Therapeutics Inc announces new drug submission for Contrave© in canada

* Orexigen Therapeutics - if approved, Valeant will market and distribute Contrave in Canada as part of its distributorship agreement with Orexigen Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below